


Welcome to the May 2013 edition of i2P - Information to pharmacists.
Economic turbulence seems to now be arriving in Australia with forecasts of high inflation rates, which also means high interest rates following on.
This type of economic forecast also means that banks will be more fractious with their borrowers. They are already offside with pharmacy due to the high level of bankruptcies over the past two years.
There is a pent up demand for a general wage increase for pharmacists impacting at a point in this month where pharmacy gross profit generally, is in decline.
Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 4 Number 1
Volume 4 Number 2
Volume 4 Number 3
Volume 4 Number 4
Volume 4 Number 5
Volume 4 Number 6
Volume 4 Number 7
Volume 4 Number 8
Volume 4 Number 9
Volume 4 Number 10
Volume 4 Number 11
Volume 5 Number 1
Volume 5 Number 2
Volume 5 Number 3
Volume 5 Number 4
Professional Pharmacists Australia Spokesperson: Professional Pharmacists Hit Out at Abbott’s Penalty Rate Plans | open full screen
i2P.com.au welcomes unsolicited contributions from interested persons.
The best way to pitch ideas and submit articles is by email to: neilj@computachem.com.au.
Include your name, contact details, a short profile and an author headshot (75 x 75 pixels, jpeg file).
Please help us cut down on editing time by submitting articles in MS Word.
Copyright remains with the author, and articles may be reproduced elsewhere but we ask that i2P.com.au is attributed with first publication.
You must warrant that your work is original, has not been published elsewhere (including online), does not breach copyright nor defame any person.
i2P.com.au will not publish material that is untrue, seeks to defame or unnecessarily distorts an issue.
We seek submissions on political and social issues in Australian Pharmacy and the world - writing that is witty not whingeing, independent not ideological, brave not bland.
Pitches for articles are welcome.
Unsolicited pieces can be submitted to a maximum length of 1200 words, an ideal length being 600-800 words.
Illustrators and cartoonists are also encouraged to submit their work.
Avoid jargon, dot points, numbered paragraphs and unexplained acronyms.
Please provide hyperlinks to any documents, media reports or websites to which the article refers.
NO footnotes, but please provide references as links or citations.
Please assume you are writing for a non-expert but engaged readership, here and overseas.
A short biographical note should be included. Anonymity, if essential, will be protected.
Suggestions for illustrations are welcome.
Dr Andrew Byrne & Associates: Effects of sublingually given naloxone in opioid-dependent human volunteers. Preston KL, Bigelow GE, Liebson IE. Drug Alcohol De | open full screen
Fiona Sartoretto Verna AIAPP: 400 sqm in Rome: the third Lapucci Pharmacy, a pharmacy full of services | open full screen
Mark Coleman: Bigger Dispensaries are not more efficient: So why have we still got the location rules? | open full screen
Anthony Huxley & Peter Krasenstein: Why extend the house if you don’t renovate it too? | open full screen
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA: Pharmacists’ Support Service welcomes support from Meridian Lawyers | open full screen
Dr Andrew Byrne & Associates: Effects of sublingually given naloxone in opioid-dependent human volunteers. Preston KL, Bigelow GE, Liebson IE. Drug Alcohol De | open full screen
If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.